GetTopicDetailResponse(id=73f71426e63, topicName=Pidilizumab, introduction=Pidilizumab, content=null, image=null, comments=1, allHits=701, url=https://h5.medsci.cn/topic?id=14267, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=15889, tagList=[TagDto(tagId=15889, tagName=Pidilizumab)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1789062, encodeId=e2f41e8906292, content=<a href='/topic/show?id=73f71426e63' target=_blank style='color:#2F92EE;'>#Pidilizumab#</a>, objectTitle=Lancet Oncol：Pidilizumab聯(lián)合利妥昔單抗治療復(fù)發(fā)性濾泡狀淋巴瘤療效顯著, objectType=article, longId=28792, objectId=8dfe28e926c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8dfe28e926c, replyNumber=0, likeNumber=98, createdTime=2014-03-03, rootId=0, userName=yangjxjc, userId=6e43278, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8dfe28e926c, moduleTitle=Lancet Oncol：Pidilizumab聯(lián)合利妥昔單抗治療復(fù)發(fā)性濾泡狀淋巴瘤療效顯著, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8dfe28e926c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話(huà)題小助手
2020-05-29
